ADVANT Altana advises the management of Kurma Partners on its sale to the Eurazeo investment group

ADVANT Altana advised the management of Kurma Partners on the acquisition of its entire share capital by Eurazeo.

Eurazeo, a long-standing investor and already a majority shareholder with a 70.6% stake since 2021, has announced the acquisition of the remaining shares in Kurma Partners, a leading French management company specialising in biotechnology and medical innovation. This transaction is in line with the agreements reached when the initial stake was acquired.

With nearly €600 million in assets under management, Kurma Partners has been a key player in European healthcare since 2009, supporting the most promising companies in the sector.

ADVANT Altana advised the management of Kurma Partners with a team including Géraldine Malfait and Jean-Nicolas Soret, partners, and Margaux Ripert, associate.